» Bookmark this page

IP Services

Home

Trademark Search

Trademark Registration

Trademark Renewal

Trademark Assignment

Request for Service

IP Resources

Intellectual Property

About Eyepea

IP & Trademark Related Book List

Intellectual Property Patents Copyrights Trademarks Intellectual Property Licensing Intellectual Property Handbook	How to Trademark How to Patent Intellectual Property Asia Intellectual Property Law Software Patent Law Pharmaceutical Patent Law
Keyword (e.g. how to patent)

Book List: pharmaceutical patent

Page: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |

	Panel recommends FDA licensure of Aventis' meningococcal vaccine.(Food and Drug Administration): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News
	Pharmacopeia achieves milestone in collaboration with Berlex.: An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News
	Aventis and Avalon form oncology collaboration.: An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News
	Celgene c-Jun N-terminal kinase inhibitor patent estate broadened with Tufts.: An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News
	Vical patent for DNA vaccines Vaxfectin adjuvant.: An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News
	GeneProt licences Oxford's automated proteomics patents.(7-year, non-exclusive automated proteomics licensing agreement)(International Pages)(Brief Article): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News
	Dynogen awarded broad United States patent relating to treatment of lower urinary tract disorders.: An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News
	InterMune and Mondobiotech form asthma collaboration.(Brief Article): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News
	Acceptys licenses human hybridoma production technology from Columbia.: An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News
	MorphoSys wins final ruling in patent dispute with CAT.(Cambridge Antibody Technology)(Brief Article): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News

	Valentis clinical trial of an intravenous IL-2 gene medicine for lung cancer is underway.(Brief Article): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News
	Xanthus receives patent on lead anti-cancer compound Xanafide amonafide.(Xanthus Life Sciences Inc.): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News
	Biosite to engineer around XOMA patent.(implementing new antibody expression technology)(Product Announcement): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News
	ActivBiotics announces expanded bacterial infection intellectual property.: An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News
	Chiron announces settlement of patent dispute over tobramycin solution.: An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News
	Alexion licenses antibody drug discovery system.(Brief Article): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News
	Pharmacopeia achieves milestone in collaboration with Berlex.: An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News
	Cincinnati Children's Hospital receives cubosome patent donation from Procter & Gamble.: An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News
	Geron and Genetic Therapy partner to develop cancer therapy.(New licensing agreement for development of therapeutic drugs for cancer)(Brief Article): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News
	Repligen licenses patent rights for treatment of mitochondrial disorders and purine autism.(Brief Article): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News

Page: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |

Eyepea Management Services is now part of Intellect Front. Based in Malaysia, Singapore, and U.S., Intellect Front specializes in trademark & intellectual property portfolio management.